Tobacco Treatment Comparison for Cancer Care

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

August 4, 2025

Study Completion Date

August 4, 2025

Conditions
Smoking CessationCancer
Interventions
DRUG

Transdermal Nicotine Patch

a stop smoking aid, 21 milligrams(mg), 14mg, or 7mg of nicotine delivered over 24 hours

BEHAVIORAL

Standard Telephone Counseling

3 brief telephone-based smoking cessation counseling sessions

DRUG

Varenicline

12 weeks of an oral smoking cessation medication

BEHAVIORAL

Cancer-Targeted Telephone Counseling

7 telephone-based smoking cessation counseling sessions adapted for cancer patients

OTHER

Mailed Information about Standard Care Resources

Publicly funded treatment resources including the SmokefreeTXT program sponsored by the National Cancer Institute and the Wisconsin Tobacco Quit Line.

Trial Locations (1)

53792

UW Carbone Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT06218823 - Tobacco Treatment Comparison for Cancer Care | Biotech Hunter | Biotech Hunter